White matter hyperintensities in myotonic dystrophy type 2: Not always another expression of the disease

被引:4
|
作者
Karatzikou, M. [1 ]
Bakirtzis, C. [1 ]
Nikolaidis, J. [1 ]
Parisis, D. [1 ]
Grigoriadis, N. [1 ]
机构
[1] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Neurol 2, Multiple Sclerosis Ctr, 1 Stilp Kyriakidi Str, GR-54636 Thessaloniki, Central Macedon, Greece
关键词
MULTIPLE-SCLEROSIS;
D O I
10.1016/j.msard.2018.06.020
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Myotonic dystrophy type 2(DM2), inherited in an autosomal, dominant manner, is clinically characterized by muscle weakness, variable myotonia, cataract and multiorgan involvement, including the Central Nervous System. Recent data from literature indicate a possible autoimmune susceptibility of patients with DM2, while white matter abnormalities are a common feature of the disease. We report herein the case of a 38-year old woman, with the rare co-existence of DM2 and MS and argue about the challenging differential diagnosis if CNS involvement is present in DM2 patients. Thus, is it another expression of a multisystem disorder or an unfortunate pure coincidence?
引用
收藏
页码:117 / 119
页数:3
相关论文
共 50 条
  • [31] Whole blood gene expression and white matter Hyperintensities
    Lin, Honghuang
    Satizabal, Claudia
    Xie, Zhijun
    Yang, Qiong
    Huan, Tianxiao
    Joehanes, Roby
    Wen, Chengping
    Munson, Peter J.
    Beiser, Alexa
    Levy, Daniel
    Seshadri, Sudha
    MOLECULAR NEURODEGENERATION, 2017, 12
  • [32] Whole blood gene expression and white matter Hyperintensities
    Honghuang Lin
    Claudia Satizabal
    Zhijun Xie
    Qiong Yang
    Tianxiao Huan
    Roby Joehanes
    Chengping Wen
    Peter J. Munson
    Alexa Beiser
    Daniel Levy
    Sudha Seshadri
    Molecular Neurodegeneration, 12
  • [33] Myotonic dystrophy type 1 - a multiorgan disease
    Orstavik, Kristin
    Solbakken, Gro
    Rasmussen, Magnhild
    Sanaker, Petter Schandl
    Fossmo, Hanne Ludt
    Bryne, Einar
    Knutsen-Oy, Torill
    Elgsas, Tonje
    Heiberg, Arvid
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2024, 144 (05)
  • [34] Eye disease in myotonic dystrophy type 1
    Boonstra, Nils-Erik
    Varhaug, Kristin N.
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2023, 143 (13) : 1146 - 1148
  • [35] Dysphagia in Myotonic Dystrophy type 2
    Tieleman, A. A.
    van Vliet, J.
    Knuijt, S.
    de Swart, B. J. M.
    Ensink, R.
    van Engelen, B. G. M.
    NEUROMUSCULAR DISORDERS, 2008, 18 (9-10) : 796 - 797
  • [36] Disease burden of myotonic dystrophy type 1
    Erik Landfeldt
    Nikoletta Nikolenko
    Cecilia Jimenez-Moreno
    Sarah Cumming
    Darren G. Monckton
    Grainne Gorman
    Chris Turner
    Hanns Lochmüller
    Journal of Neurology, 2019, 266 : 998 - 1006
  • [37] Disease burden of myotonic dystrophy type 1
    Landfeldt, Erik
    Nikolenko, Nikoletta
    Jimenez-Moreno, Cecilia
    Cumming, Sarah
    Monckton, Darren G.
    Gorman, Grainne
    Turner, Chris
    Lochmueller, Hanns
    JOURNAL OF NEUROLOGY, 2019, 266 (04) : 998 - 1006
  • [38] Diffusion tensor imaging of cerebral white matter in patients with myotonic dystrophy
    Tikkakoski, T
    ACTA RADIOLOGICA, 2005, 46 (01) : 2 - 2
  • [39] Magnetization transfer measurements of cerebral white matter in patients with myotonic dystrophy
    Naka, H
    Imon, Y
    Ohshita, T
    Honjo, K
    Kitamura, T
    Mimori, Y
    Nakamura, S
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 193 (02) : 111 - 116
  • [40] Cortical Thickness and White Matter Integrity are Associated with CTG Expansion Size in Myotonic Dystrophy Type I
    Yoo, Woo-Kyoung
    Park, Yoon Ghil
    Choi, Young Chul
    Kim, Sun Mi
    YONSEI MEDICAL JOURNAL, 2017, 58 (04) : 807 - 815